logo
episode-header-image
May 2022
53m 59s

207. Lipids: REDUCE-IT Versus STRENGTH T...

CARDIONERDS
About this episode
CardioNerds Tommy Das (Program Director of the CardioNerds Academy and cardiology fellow at Cleveland Clinic), Rick Ferraro (cardiology fellow at the Johns Hopkins Hospital), and Dr. Aliza Hussain (cardiology fellow at Baylor College Medicine) take a deep dive on the REDUCE-IT trial with Dr. Peter Toth, director of preventive cardiology at the CGH medical ce ... Show More
Up next
Aug 19
424. Treatment of Transthyretin Amyloid Cardiomyopathy (ATTR-CM) with Dr. Justin Grodin
CardioNerds (Drs. Rick Ferraro and Georgia Vasilakis Tsatiris) discuss ATTR cardiac amyloidosis with expert Dr. Justin Grodin. This episode is a must-listen for all who want to know how to diagnose and treat ATTR with current available therapies, as well as management of concomit ... Show More
44m 38s
Aug 3
423. Case Report: The Malignant Murmur – More Than Meets the Echo in Nonbacterial Thrombotic Endocarditis – Baylor College of Medicine
CardioNerds (Dr. Rick Ferraro and Dr. Dan Ambinder) join Dr. Sahar Samimi and Dr. Lorraine Mascarenhas from Baylor College of Medicine, Houston, Texas, at the Houston Rodeo for some tasty Texas BBQ and a tour of the lively rodeo grounds to discuss an interesting case full of clin ... Show More
16m 3s
Jul 25
422. Diagnosis of Transthyretin Amyloid Cardiomyopathy (ATTR-CM) with Dr. Venkatesh Murthy
Drs. Rick Ferraro and Sneha Nandy discuss ‘Diagnosis of ATTR Cardiac Amyloidosis’ with Dr. Venkatesh Murthy. In this episode, we explore the diagnosis of ATTR cardiac amyloidosis, a condition once considered rare but now increasingly recognized due to advances in imaging and the ... Show More
13m 38s
Recommended Episodes
Jan 2024
Review of the Cardiac Arrhythmia Suppression Trial (CAST)
NEJM 1991;324:781-788Background A hallmark of post-myocardial infarction (MI) care in the 1980’s was the monitoring and suppression of premature ventricular contractions (PVCs) via use of antiarrhythmic drugs. The practice was based on pathophysiologic rationale that PVC burden i ... Show More
6m 58s
May 2024
Episode 904: Cardiovascular Risks of Epinephrine
Contributor: Aaron Lessen MD Educational Pearls: Epinephrine is essential in the treatment of anaphylaxis, but is epinephrine dangerous from a cardiovascular perspective? A 2024 study in the Journal of the American College of Emergency Physicians Open sought to answer this questi ... Show More
2m 11s
Feb 2024
Review of the MIRACL Trial
JAMA 2001;285:1711-18.Background Statin therapy had been shown to improve blood cholesterol and improve long-term outcomes in patients with stable coronary artery disease with significant effects evident after 2 years of treatment. These early trials excluded patients with recent ... Show More
11m 1s
Jan 2024
ACCEL Lite: Pitavastatin to Prevent Cardiovascular Disease in HIV Infection
While we know that statin treatment reduces the risk of stroke, heart attack and heart deaths in people at moderate-to-high risk, or with high cholesterol, in REPRIEVE statins decreased the risk in those at low-to-moderate risk, and with 'normal' cholesterol levels who would not ... Show More
11m 46s
Jul 2021
Novel Lipid-Lowering Therapies to Reduce Cardiovascular Risk
Several new therapeutic drug classes are now available to manage lipid levels. John Wilkins, MD, MS, and Donald Lloyd-Jones, MD, ScM, of the Department of Preventive Medicine and Division of Cardiology at Northwestern University Feinberg School of Medicine, discuss the use of eze ... Show More
35m 24s
Jun 2024
GU Oncology Highlights From ASCO24
Dr. Neeraj Agarwal and Dr. Rana McKay discuss promising studies in GU cancers featured at the 2024 ASCO Annual Meeting that highlighted improved outcomes in urothelial carcinoma, improved survival in renal cell carcinoma, and the role of ctDNA as a potential biomarker for predict ... Show More
34m 54s
Mar 2024
Episode 895: Indications for Exogenous Albumin
Contributor: Travis Barlock MD Educational Pearls: There are three indications for IV albumin in the ED Spontaneous bacterial peritonitis (SBP) Patients with SBP develop renal failure from volume depletion Albumin repletes volume stores and reduces renal impairment Albumin binds ... Show More
2m 28s
Jun 2024
Review of the CIRT trial
N Engl J Med 2019;380:752-762Background: Growing body of evidence suggests the role of inflammation in atherosclerosis. The CANTOS trial, discussed earlier, provided further evidence for that hypothesis. In the CANTOS trial, canakinumab a monoclonal antibody that neutralizes inte ... Show More
9m 30s
Jun 2024
#525: Cholesterol-Lowering Medication – Dr. Paddy Barrett
Cholesterol-lowering medications, particularly statins, play a pivotal role in reducing low-density lipoprotein cholesterol (LDL-C) and apolipoprotein B (apoB) concentrations, which are causal markers in atherosclerosis development. The efficacy of these medications is well-docum ... Show More
48m 29s
Jul 2019
LDL-Senkung 4.0
Kombinationspartner zur Statintherapie in Sicht? Studientelegramm 72-2019-2/3 Titel der Studie: Safety and Efficacy of Bempedoic Acid to Reduce LDL Cholesterol Autoren: Ray et al. Journal: New England Journal of Medicine (NEJM) Studientelegramm 72-2019-3/3 Titel der Studie: Mende ... Show More
8m 59s